相似文献
1
Chitosan and its derivatives as vehicles for drug delivery.
Drug Deliv. 2017;24(sup1):108-113. doi: 10.1080/10717544.2017.1399305.
2
Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
Mol Pharm. 2016 May 2;13(5):1455-66. doi: 10.1021/acs.molpharmaceut.5b00859. Epub 2016 Apr 18.
3
Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Int J Pharm. 2011 Jul 15;413(1-2):229-36. doi: 10.1016/j.ijpharm.2011.04.031. Epub 2011 Apr 21.
4
Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Eur J Pharm Biopharm. 2015 Jan;89:74-81. doi: 10.1016/j.ejpb.2014.11.026. Epub 2014 Dec 3.
5
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Eur J Pharm Biopharm. 2017 Nov;120:89-97. doi: 10.1016/j.ejpb.2017.08.013. Epub 2017 Sep 1.
6
Chitosan-based gastroretentive floating drug delivery technology: an updated review.
Expert Opin Drug Deliv. 2012 May;9(5):525-39. doi: 10.1517/17425247.2012.673581. Epub 2012 Mar 24.
7
Advances in chitosan-based drug delivery vehicles.
Nanoscale. 2013 Apr 21;5(8):3103-11. doi: 10.1039/c3nr00338h. Epub 2013 Mar 21.
8
Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
AAPS PharmSciTech. 2011 Mar;12(1):10-20. doi: 10.1208/s12249-010-9561-2. Epub 2010 Dec 11.
9
Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Pharm Nanotechnol. 2017;5(4):243-249. doi: 10.2174/2211738505666170808095258.
10
Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery.
Eur J Pharm Sci. 2017 Mar 1;99:137-146. doi: 10.1016/j.ejps.2016.12.013. Epub 2016 Dec 15.
引用本文的文献
1
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.
Cancer Cell Int. 2025 Mar 19;25(1):104. doi: 10.1186/s12935-025-03702-4.
2
Nanoparticles for the treatment of spinal cord injury.
Neural Regen Res. 2025 Jun 1;20(6):1665-1680. doi: 10.4103/NRR.NRR-D-23-01848. Epub 2024 May 13.
3
Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines.
Vaccines (Basel). 2024 Mar 21;12(3):339. doi: 10.3390/vaccines12030339.
4
Role of Polymer Concentration on the Release Rates of Proteins from Single- and Double-Network Hydrogels.
Int J Mol Sci. 2023 Nov 30;24(23):16970. doi: 10.3390/ijms242316970.
5
The important role of miR-1-3p in cancers.
J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8.
6
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy.
Front Chem. 2023 Sep 28;11:1259435. doi: 10.3389/fchem.2023.1259435. eCollection 2023.
7
Chitosan/Alginate Polymeric Nanoparticle-Loaded α-Mangostin: Characterization, Cytotoxicity, and In Vivo Evaluation against Breast Cancer Cells.
Polymers (Basel). 2023 Sep 5;15(18):3658. doi: 10.3390/polym15183658.
8
The Application of Nanogels as Efficient Drug Delivery Platforms for Dermal/Transdermal Delivery.
Gels. 2023 Sep 15;9(9):753. doi: 10.3390/gels9090753.
9
Advances in Polysaccharide- and Synthetic Polymer-Based Vitreous Substitutes.
Pharmaceutics. 2023 Feb 8;15(2):566. doi: 10.3390/pharmaceutics15020566.
10
Improvement of Therapeutic Value of Quercetin with Chitosan Nanoparticle Delivery Systems and Potential Applications.
Int J Mol Sci. 2023 Feb 7;24(4):3293. doi: 10.3390/ijms24043293.
本文引用的文献
1
Chitosan derivatives as effective nanocarriers for ocular release of timolol drug.
Int J Pharm. 2015 Nov 10;495(1):249-264. doi: 10.1016/j.ijpharm.2015.08.100. Epub 2015 Sep 1.
2
One-pot synthesis of antibacterial chitosan/silver bio-nanocomposite hydrogel beads as drug delivery systems.
Int J Biol Macromol. 2015 Aug;79:37-43. doi: 10.1016/j.ijbiomac.2015.04.032. Epub 2015 Apr 27.
3
Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
Biomed Pharmacother. 2014 Oct;68(8):979-87. doi: 10.1016/j.biopha.2014.10.009. Epub 2014 Oct 30.
4
Cyclodextrin-grafted chitosan hydrogels for controlled drug delivery.
Int J Biol Macromol. 2015 Jan;72:299-308. doi: 10.1016/j.ijbiomac.2014.08.030. Epub 2014 Sep 2.
5
Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
Acta Biomater. 2014 Oct;10(10):4360-6. doi: 10.1016/j.actbio.2014.05.031. Epub 2014 Jun 7.
6
Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.
Eur J Pharm Biopharm. 2014 Oct;88(2):361-73. doi: 10.1016/j.ejpb.2014.05.015. Epub 2014 May 22.
7
Polymeric nanocarriers for siRNA delivery to murine macrophages.
Macromol Biosci. 2014 Aug;14(8):1096-105. doi: 10.1002/mabi.201400027. Epub 2014 Apr 22.
8
Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin.
Int J Pharm. 2014 Apr 10;464(1-2):127-34. doi: 10.1016/j.ijpharm.2014.01.015. Epub 2014 Jan 19.
9
Design, synthesis and in vitro evaluation of mucoadhesive p-coumarate-thiolated-chitosan as a hydrophobic drug carriers.
Eur J Pharm Biopharm. 2014 Apr;86(3):487-97. doi: 10.1016/j.ejpb.2013.11.009. Epub 2013 Dec 9.
10
Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA.
Int J Biomater. 2013;2013:146320. doi: 10.1155/2013/146320. Epub 2013 Sep 30.
Zotero 插件